Blue Fin Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.46M Buy
+13,603
New +$1.46M 0.25% 63
2024
Q4
$979K Buy
10,963
+550
+5% +$49.1K 0.18% 75
2024
Q3
$873K Buy
10,413
+406
+4% +$34K 0.17% 81
2024
Q2
$771K Buy
10,007
+1,419
+17% +$109K 0.15% 81
2024
Q1
$588K Buy
8,588
+706
+9% +$48.4K 0.13% 89
2023
Q4
$456K Sell
7,882
-142
-2% -$8.21K 0.12% 93
2023
Q3
$424K Buy
8,024
+1,334
+20% +$70.4K 0.12% 94
2023
Q2
$362K Hold
6,690
0.1% 107
2023
Q1
$347K Hold
6,690
0.11% 105
2022
Q4
$310K Hold
6,690
0.11% 108
2022
Q3
$259K Sell
6,690
-122
-2% -$4.72K 0.1% 111
2022
Q2
$253K Hold
6,812
0.09% 116
2022
Q1
$301K Sell
6,812
-55
-0.8% -$2.43K 0.09% 113
2021
Q4
$291K Sell
6,867
-171
-2% -$7.25K 0.08% 116
2021
Q3
$305K Sell
7,038
-316
-4% -$13.7K 0.09% 103
2021
Q2
$314K Sell
7,354
-321
-4% -$13.7K 0.1% 98
2021
Q1
$296K Sell
7,675
-422
-5% -$16.3K 0.1% 101
2020
Q4
$291K Sell
8,097
-672
-8% -$24.2K 0.1% 97
2020
Q3
$335K Buy
8,769
+661
+8% +$25.3K 0.14% 90
2020
Q2
$284K Buy
8,108
+646
+9% +$22.6K 0.13% 94
2020
Q1
$243K Buy
7,462
+300
+4% +$9.77K 0.13% 102
2019
Q4
$322K Buy
7,162
+656
+10% +$29.5K 0.15% 108
2019
Q3
$264K Sell
6,506
-278
-4% -$11.3K 0.14% 110
2019
Q2
$291K Buy
6,784
+431
+7% +$18.5K 0.15% 110
2019
Q1
$243K Buy
+6,353
New +$243K 0.13% 118
2014
Q2
Sell
-16,600
Closed -$224K 130
2014
Q1
$224K Sell
16,600
-875
-5% -$11.8K 0.2% 110
2013
Q4
$210K Buy
+17,475
New +$210K 0.19% 114